TYRO3 is a member of the TAM family of RTKs, and aberrant expression of the TYRO3/PI3K/AKT signaling pathway is a novel mechanism of acquired resistance to sorafenib in HCC. The gene discussed is TYRO3; the disease is hepatocellular carcinoma.